Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness
International Journal of Biological Sciences · 2024 · 20 (13) · 5208-5222
DOI: 10.7150/ijbs.100355 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Giovanni Luca Beretta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm, Deubiquitinating Enzymes. Die Arbeit wurde bisher 25-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy.
Zitieren
APA
Beretta, G. L., Costantino, M., Mirra, L., Pettinari, P., & Perego, P. (2024). Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness. International Journal of Biological Sciences, 20(13), 5208-5222. https://doi.org/10.7150/ijbs.100355
Vancouver
Beretta GL, Costantino M, Mirra L, Pettinari P, Perego P. Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness. International Journal of Biological Sciences. 2024;20(13):5208-5222. doi:10.7150/ijbs.100355
BibTeX
@article{Beretta2024,
author = {Beretta, Giovanni Luca and Costantino, Matteo and Mirra, Luca and Pettinari, Pietro and Perego, Paola},
title = {Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {13},
pages = {5208--5222},
doi = {10.7150/ijbs.100355}
}
EUVIMED